# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-077777
Filing Date
2024-03-27
Accepted
2024-03-26 18:26:27
Documents
125

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-1/A | d791869ds1a.htm iXBRL | S-1/A | 2836029
2 | EX-5.1 | d791869dex51.htm | EX-5.1 | 7779
3 | EX-23.1 | d791869dex231.htm | EX-23.1 | 1404
4 | EX-23.2 | d791869dex232.htm | EX-23.2 | 1458
10 | GRAPHIC | g791869g0202154215941.jpg | GRAPHIC | 2221
11 | GRAPHIC | g791869g08m07.jpg | GRAPHIC | 112060
12 | GRAPHIC | g791869g40p53.jpg | GRAPHIC | 123237
13 | GRAPHIC | g791869g61v60.jpg | GRAPHIC | 103695
14 | GRAPHIC | g791869g68p81.jpg | GRAPHIC | 64161
15 | GRAPHIC | g791869g81i79.jpg | GRAPHIC | 35007
16 | GRAPHIC | g791869g82k34.jpg | GRAPHIC | 88399
| Complete submission text file | 0001193125-24-077777.txt |  | 13420641

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | syre-20231231.xsd | EX-101.SCH | 90333
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | syre-20231231_cal.xml | EX-101.CAL | 59200
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | syre-20231231_def.xml | EX-101.DEF | 529955
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syre-20231231_lab.xml | EX-101.LAB | 730925
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syre-20231231_pre.xml | EX-101.PRE | 683371
129 | EXTRACTED XBRL INSTANCE DOCUMENT | d791869ds1a_htm.xml | XML | 1772877

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-276251 | Film No.: 24785187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)